JPRN-UMIN000021963已完成未知
Special Drug Use-Results Survey for IMBRUVICA Capsules 140 mg - Special Drug Use-Results Survey for IMBRUVICA Capsules 140 mg
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Special Drug-Use Results Survey of IMBRUVICA Capsules 140 mg (relapsed or refractory mantle cell lymphoma [MCL])Relapsed or refractory mantle cell lymphomaJPRN-UMIN000028130Janssen Pharmaceutical K.K.200
招募中
Unknown
Intuniv Tablets drug use-results survey (Surveillance regarding pediatric use)Attention Deficit/Hyperactivity DisorderJPRN-jRCT1080223870SHIONOGI & CO., LTD.75
进行中（未招募）
不适用
Protocol Number; CAIN457L1401JPRN-jRCT2031210589Toshiya Sugimoto35
已完成
Unknown
Special Drug Use-Results Survey of ParsabivSecondary hyperparathyroidism on hemodidalysisJPRN-jRCT1080224015ONO PHARMACEUTICAL CO.,LTD.1,200
招募中
Unknown
Special Drug Use-Results Survey (All-Case Surveillance) to Investigate Safety and Effectiveness in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Empaveli in the Post-Marketing Clinical Use in JapaParoxysmal nocturnal hemoglobinuriaJPRN-jRCT2031230275Shimmoto Naoki100